Aldehyde-Releasing Reagent for Antigen Retrieval in Fixed Tissue

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Aldehyde fixation methods for tissue samples lead to antigenic loss due to cross-linking reactions, which hampers immunohistochemical analyses, and existing antigen retrieval methods are limited by requiring external heat sources or being unsuitable for celloidin-embedded or decalcified bony tissues.

Innovation Solution

Treatment of aldehyde-fixed tissues with nucleophilic, oxidizing, or organic acid/base pair agents to catalyze the reversal of Mannich/Schiff's Base reactions, converting aldehydes into non-reactive forms, thereby restoring antigenicity, suitable for celloidin-embedded and decalcified bony tissues without external heat.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If aldehyde fixation is used to preserve tissue morphology and integrity, then tissue structural stability is improved, but antigenicity is lost due to cross-linking reactions

Engineering Contradiction:
Improvetissue structural stabilityVSAvoidantigenicity
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent applies preliminary proteolytic enzyme treatment to aldehyde-fixed tissue sections before immunohistochemical staining. This preliminary action breaks down the cross-linked protein structures formed during aldehyde fixation, thereby restoring antigen accessibility without compromising the already-preserved tissue morphology. The enzyme treatment is performed as a preparatory step that reverses the harmful cross-linking effects while maintaining the structural integrity achieved during fixation.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If alternative fixation methods like microwave heating or alcohol immersion are used to preserve antigenicity, then antigen retrieval is improved, but tissue morphology and membrane integrity deteriorate

Engineering Contradiction:
ImproveantigenicityVSAvoidtissue morphology
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent introduces proteolytic enzymes as an intermediary substance that mediates between the conflicting requirements of preserving tissue morphology and restoring antigenicity. Rather than using extreme methods like microwave heating or alcohol fixation that directly damage tissue structure, the enzyme acts as a gentle intermediary that selectively breaks down cross-linked proteins to expose antigens while leaving the overall tissue architecture intact. This intermediary approach allows simultaneous achievement of both morphological preservation and antigen retrieval.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If protease treatment is applied to restore antigenicity in aldehyde-fixed tissues, then immunoreactivity is improved, but existing methods are limited by requiring external heat sources or being unsuitable for celloidin-embedded or decalcified bony tissues

Engineering Contradiction:
ImproveimmunoreactivityVSAvoidmethod applicability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent develops a universal proteolytic enzyme treatment protocol that can be applied to multiple types of tissue samples including paraffin-embedded sections, celloidin-embedded sections, and decalcified bony tissues. The method uses proteolytic enzymes that function effectively across different embedding media and tissue types without requiring modification of the basic protocol or external heat sources. This multi-functional approach allows the same enzymatic treatment to restore antigenicity in diverse fixed tissue samples, greatly expanding the applicability of antigen retrieval techniques.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Effectively restores immunoreactivity in aldehyde-fixed tissues, enabling enhanced immunohistochemical staining of previously inaccessible samples, including decalcified bony tissues, without the need for external heat, and is compatible with various embedding media.

Implementation Method 1

catalyze the reversal of Mannich/Schiff's Base reactions, converting aldehydes into non-reactive forms

Methodology Applied
Scientific EffectMannich reaction reversal: Chemical Bonding

Implementation Method 2

catalyze the reversal of Mannich/Schiff's Base reactions

Methodology Applied
Scientific EffectSchiff's base reaction reversal: Chemical Bonding

Implementation Method 3

Treatment of aldehyde-fixed tissues with nucleophilic, oxidizing, or organic acid/base pair agents to catalyze the reversal of Mannich/Schiff's Base reactions

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUSRE40835E1Enhancement of immunochemical staining in aldehyde-fixed tissue
Publication Date: 2009.07.07 BIOGENEX LAB INC

AI summary

A method for restoring immunoreactivity of a tissue, particularly decalcified tissue, fixed width an aldehyde fixative agent and embedded in an embedding medium, usually comprising celloidin, the method comprising the steps of contacting the tissue with an aldehyde releasing reagent solution comprising a solvent and an aldehyde releasing reagent and removing aldehyde released by the aldehyde releasing reagent from contact with the tissue by reacting the aldehyde in a substantially irreversible manner to form a non-aldehyde derivative, and removing excess base from the tissue. A preferred solution for celloidin-embedded decalcified tissue comprises methanolic sodium hydroxide at about one-third saturation.